By setting the “baseline” level for activity in neural networks, the NMDAR helps maintain stable brain function amidst ...

Researchers at Tel Aviv University have made a fundamental discovery: the NMDA receptor (NMDAR)—long studied primarily for ...

Enlivex Therapeutics Ltd. (Nasdaq: ENLV, the "Company”), a clinical-stage macrophage reprogramming immunotherapy company, ...

Quince Therapeutics, Inc. (Nasdaq: QNCX), a late-stage biotechnology company dedicated to unlocking the power of a patient's own biology for the treatment of rare diseases, today announced the ...

The primary exposures of interest were Apnea-Hypopnea Index (AHI) and CRP levels. The primary outcomes of interest were hypertension and insulin resistance, measured via blood pressure readings and ...

Weight loss from behavioral changes or medication can improve glycemic control and increase menstrual frequency in polycystic ...

Favorable capital market conditions last week enabled the company to raise over $15 million from secondary offerings, and the proceeds allow the Company to fund fully the costs of this upcoming ...

A prism that makes us more confused and more discouraged? We don't know what to believe, who to believe or who to trust.

At the time, Daylight Saving Time was believed to help conserve fuel, but nowadays many believe that the shift is necessary ...

Enlivex Therapeutics Ltd. (Nasdaq: ENLV, the “Company”), a clinical-stage macrophage reprogramming immunotherapy company, ...

Results provide a mechanistic explanation of why early loss of p53 signaling is frequently observed in UC-associated ...